New Enterprise Associates
ActiveFiled to raiseTimonium, MDLast fund filed January 2025Biotechnology, Healthcare, Pharmaceuticals
Timonium, MDLast fund filed January 2025Biotechnology, Healthcare, Pharmaceuticals
0 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| NEA 19 Access Fund, L.P.Filed to raise, with no closing reported yet. | January 2025 | Indefinite | $0 | 0 |
| NEA 19 Venture Growth Equity, L.P.Filed to raise, with no closing reported yet. | January 2025 | Indefinite | $0 | 0 |
| New Enterprise Associates 19, L.P.Filed to raise, with no closing reported yet. | January 2025 | Indefinite | $0 | 0 |
| NEA Secondary Opportunity Fund, L.P. | July 2024 | $468.2M | $468.2M | 60 |
| NEA TS 2024 SPV, L.P. | June 2024 | $140.0M | $155.0M | 20 |
| NEA CH SPV, L.P. | May 2024 | $65.0M | $65.0M | 20 |
| NEA RP SPV, L.P. | February 2024 | $244.6M | $244.6M | 3 |
| Point 406 Ventures Opportunities Fund III, L.P.Filed to raise, with no closing reported yet. | January 2024 | $50.0M | $0 | 0 |
| NEA SH SPV, L.P. | April 2023 | $7.5M | $12.5M | 1 |
| NEA 18 Venture Growth Equity, L.P. | December 2021 | $3.70B | $2.33B | 244 |
| New Enterprise Associates 18, L.P. | December 2021 | $2.90B | $2.85B | 271 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. Form D carries no per-investor amount, so a firm’s own cheque is not recoverable here.
12 partners are named across this firm’s filings, 0 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats, 24mo |
|---|---|---|---|
| Mohamad MakhzoumiOn the current fund | Selective | None listed | 3 |
| Edward MathersOn the current fund | Selective | None listed | 2 |
| Rick YangOn the current fund | Slowing | None listed | 1 |
| Ali BehbahaniOn the current fund | Quiet | None listed | 0 |
| Carmen Chang | Quiet | None listed | 0 |
| Liam Donohue | Quiet | None listed | 0 |
| Liza Landsman Gold | Quiet | None listed | 0 |
| Paul WalkerOn the current fund | Quiet | None listed | 0 |
| Payal Divakaran | Quiet | None listed | 0 |
| Peter Sonsini | Quiet | None listed | 0 |
| Scott SandellOn the current fund | Quiet | None listed | 0 |
| Tony FlorenceOn the current fund | Quiet | None listed | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. On a firm it is the total across its partners, so an active firm may be four partners taking one seat each rather than one person moving fast. It undercounts partners who invest without taking a board seat, and Form D lags a closing by weeks — so Quiet means the paperwork is quiet, not the person.